News

The Summer 2018 CMTA Report PDF is now available. In addition to our regular features, you’ll find these articles and items of interest: STAR: The CMTA’s Plan for Finding Treatments and Cures for CMT CMTA Research Spotlight: Alliance ...

Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, announced a collaboration with the CMTA to validate the role of HDAC6 in multiple forms of CMT disease and evaluate the efficacy of ricolinostat, a selective HDAC6 inhibitor.

The Charcot-Marie-Tooth Association (CMTA), a patient organization focused on supporting the development of innovative medicines for Charcot-Marie-Tooth (CMT) disease, today announced a strategic partnership with Acceleron Pharma, a Cambridge-based biopharmaceutical company dedicated to developing medicines ...

Amy Keller had always known about CMT as it runs in her family. But, as a healthy, active child who grew up into a symptom-free adult, it had never crossed her mind that she, too, ...

The start of a new year brings resolutions to work on becoming more fit. It can be exciting to start something new, but by mid-January, many of us are asking whether our goals are reasonable ...